4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease
Considering that acetylcholinesterase (AChE) inhibition is the most important mode of action expected of a potential drug used for the treatment of symptoms of Alzheimer’s disease (AD), our previous pilot study of 4-aminoquinolines as potential human cholinesterase inhibitors was extended to twenty-...
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2022-06-01
|
| Seria: | Pharmaceutics |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/1999-4923/14/6/1305 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
